Company Profile
Polares Medical is a Switzerland-based clinical-stage manufacturer of transcatheter mitral valve therapies, headquartered in Lausanne, Switzerland, with U.S. operations in Palo Alto, California. Founded in 2017 as a spin-off from Symetis SA (acquired by Boston Scientific Corporation in 2017), the company operates as an independent private entity, serving global structural heart markets with clinical programs across the U.S., Europe, and Australia.
Core Products & Technologies
Transcatheter Mitral Valve Therapies
• MRace Posterior Leaflet Replacement System: Transcatheter implant restoring posterior leaflet function to treat mitral regurgitation
• MRace Delivery System: Proprietary catheter platform enabling precise implant deployment and positioning
Clinical Development
• MRace Global Clinical Program: Multi-regional trials evaluating safety and efficacy in degenerative and functional MR patients
Market Position & Certifications
Polares Medical holds an emerging leadership position in the global transcatheter mitral valve replacement market, competing with Abbott (MitraClip/TEER) and Edwards Lifesciences. Key strengths include:
• 9 years of Swiss engineering heritage in structural heart innovation
• Posterior Leaflet Replacement: Novel hemi-replacement approach preserving future treatment pathways
• Clinical evidence: 70+ patients implanted with sustained one-year safety and efficacy data
• Regulatory status: Clinical-stage device under investigation in FDA-supervised trials (not yet commercially cleared)
• Venture backing: $50M Series C (March 2026) to advance U.S. and global clinical studies
Corporate Timeline
2017 — Founded in Lausanne, Switzerland, as a spin-off from Symetis SA
2026 — Closed $50M Series C financing (March) to drive U.S. expansion and global clinical trials
Target Markets & Applications
• Mitral Regurgitation (MR): MRace system for degenerative and functional MR patients
• Secondary MR: Transcatheter alternative to edge-to-edge repair (TEER) for complex anatomies
• Structural Heart Disease: Minimally invasive mitral therapies avoiding open-heart surgery
Contact Information
Global Headquarters
Address: Chemin de Mornex 6, 1003 Lausanne, Switzerland
Telephone: +41 21 310 11 20
U.S. Operations
Address: 1070E Meadow Cir., Palo Alto, CA 94303, USA
Telephone: (650) 800-7777
Corporate Status
Entity Type: Independent Private Company (No Parent Company)
Stock: Not Publicly Traded
Website: polaresmedical.com
